JPWO2021261444A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021261444A5 JPWO2021261444A5 JP2022531976A JP2022531976A JPWO2021261444A5 JP WO2021261444 A5 JPWO2021261444 A5 JP WO2021261444A5 JP 2022531976 A JP2022531976 A JP 2022531976A JP 2022531976 A JP2022531976 A JP 2022531976A JP WO2021261444 A5 JPWO2021261444 A5 JP WO2021261444A5
- Authority
- JP
- Japan
- Prior art keywords
- tetradecanoyl
- oxy
- pharma
- acceptable salt
- decanoyloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000003839 salts Chemical class 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 16
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 14
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 claims 11
- 125000003118 aryl group Chemical group 0.000 claims 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 239000000427 antigen Substances 0.000 claims 7
- 102000036639 antigens Human genes 0.000 claims 7
- 108091007433 antigens Proteins 0.000 claims 7
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 7
- 235000019260 propionic acid Nutrition 0.000 claims 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 238000009472 formulation Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 244000052769 pathogen Species 0.000 claims 3
- 230000001717 pathogenic effect Effects 0.000 claims 3
- 239000012646 vaccine adjuvant Substances 0.000 claims 3
- 229940124931 vaccine adjuvant Drugs 0.000 claims 3
- 208000035473 Communicable disease Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- -1 inorganic acid salts Chemical class 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 150000003904 phospholipids Chemical class 0.000 claims 2
- CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000013345 egg yolk Nutrition 0.000 claims 1
- 210000002969 egg yolk Anatomy 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020107194 | 2020-06-22 | ||
| PCT/JP2021/023402 WO2021261444A1 (ja) | 2020-06-22 | 2021-06-21 | Tlr4作動活性を有するアジュバント |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021261444A1 JPWO2021261444A1 (https=) | 2021-12-30 |
| JPWO2021261444A5 true JPWO2021261444A5 (https=) | 2024-06-25 |
Family
ID=79281148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022531976A Withdrawn JPWO2021261444A1 (https=) | 2020-06-22 | 2021-06-21 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20230287027A1 (https=) |
| EP (1) | EP4169527A4 (https=) |
| JP (1) | JPWO2021261444A1 (https=) |
| KR (1) | KR20230026438A (https=) |
| CN (1) | CN116056721A (https=) |
| AU (1) | AU2021295796A1 (https=) |
| BR (1) | BR112022025969A2 (https=) |
| CA (1) | CA3187828A1 (https=) |
| CL (1) | CL2022003689A1 (https=) |
| IL (1) | IL299253A (https=) |
| MX (1) | MX2022016181A (https=) |
| PE (1) | PE20230463A1 (https=) |
| PH (1) | PH12022553464A1 (https=) |
| SA (1) | SA522441781B1 (https=) |
| WO (1) | WO2021261444A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026018889A1 (ja) * | 2024-07-19 | 2026-01-22 | 住友ファーマ株式会社 | ワクチンアジュバントを含むリポソーム製剤 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| ATE518874T1 (de) | 1999-11-15 | 2011-08-15 | Oncothyreon Inc | Synthetische lipid-a analogen und verwendungen davon |
| CN101863930A (zh) | 2003-01-06 | 2010-10-20 | 科里克萨有限公司 | 一些氨烷基氨基葡糖苷磷酸酯化合物和它们的用途 |
| US7807720B2 (en) | 2007-02-01 | 2010-10-05 | Panthera Biopharma, Llc | Hydroxamic acid derivatives of 3-phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning |
| CN105188710A (zh) * | 2013-03-15 | 2015-12-23 | 葛兰素史密丝克莱恩生物有限公司 | 包含缓冲的氨基烷基氨基葡糖苷磷酸酯衍生物的组合物及其用于增强免疫应答的用途 |
| EP3242883A4 (en) * | 2015-01-06 | 2018-10-17 | ImmunoVaccine Technologies Inc. | Lipid a mimics, methods of preparation, and uses thereof |
| JP7362667B2 (ja) * | 2018-02-12 | 2023-10-17 | イニミューン・コーポレーション | Toll様受容体リガンド |
-
2021
- 2021-06-21 IL IL299253A patent/IL299253A/en unknown
- 2021-06-21 PH PH1/2022/553464A patent/PH12022553464A1/en unknown
- 2021-06-21 US US18/011,586 patent/US20230287027A1/en active Pending
- 2021-06-21 MX MX2022016181A patent/MX2022016181A/es unknown
- 2021-06-21 CA CA3187828A patent/CA3187828A1/en active Pending
- 2021-06-21 BR BR112022025969A patent/BR112022025969A2/pt unknown
- 2021-06-21 EP EP21829834.7A patent/EP4169527A4/en not_active Withdrawn
- 2021-06-21 KR KR1020237001883A patent/KR20230026438A/ko active Pending
- 2021-06-21 PE PE2022002961A patent/PE20230463A1/es unknown
- 2021-06-21 JP JP2022531976A patent/JPWO2021261444A1/ja not_active Withdrawn
- 2021-06-21 WO PCT/JP2021/023402 patent/WO2021261444A1/ja not_active Ceased
- 2021-06-21 CN CN202180051288.3A patent/CN116056721A/zh active Pending
- 2021-06-21 AU AU2021295796A patent/AU2021295796A1/en not_active Abandoned
-
2022
- 2022-12-18 SA SA522441781A patent/SA522441781B1/ar unknown
- 2022-12-21 CL CL2022003689A patent/CL2022003689A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514001A5 (https=) | ||
| JP2021526133A5 (https=) | ||
| JP2007502804A5 (https=) | ||
| JP2024504932A5 (https=) | ||
| JP2022536728A5 (https=) | ||
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| JP2010540525A5 (https=) | ||
| JP2024522990A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP2013534248A5 (https=) | ||
| JPWO2022014639A5 (https=) | ||
| JP2020515610A5 (https=) | ||
| JP2015518004A5 (https=) | ||
| JP2022137237A5 (https=) | ||
| JP2017518959A5 (https=) | ||
| RU2009102278A (ru) | Модуляторы рецептора s1p для лечения рассеянного склероза | |
| RU2007147344A (ru) | Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний | |
| JP2010526801A5 (https=) | ||
| JP2020532546A5 (https=) | ||
| JP2014519507A5 (https=) | ||
| JP2013526520A5 (https=) | ||
| JP2011517697A5 (https=) | ||
| JPWO2021261444A5 (https=) | ||
| JP2024501257A5 (https=) | ||
| RU2007147340A (ru) | Новые производные 2-азетидинона в качестве ингибиторов всасывания холестерина для лечения гиперлипидемических состояний |